1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLCLocally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)RecruitingPhase 22025-11-26NCT07058519